Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |